Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Normal saline versus Plasma-Lyte in critically ill ICU patients
ACTRN12615000158561Phase 2Completed
- Sponsor
- Austin Hospital
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Normal Saline-Benha University and plasma-lyte in critical illness (2 arms), sponsored by Austin Hospital. Primary endpoint: Base excess. Started Jun 2016; status: completed.
02
Drugs
Normal Saline-Benha Universityplasma-lyte
03
Conditions
critical illness
Beyond the preview
Go deeper on ACTRN12615000158561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000158561.